Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) had its price target lowered by analysts at Mizuho from $4.00 to $3.00. They now have a "neutral" rating on the stock.
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 Loss, Lags Revenue Estimates [Yahoo! Finance]
Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results